EX-23.2 6 ex-23_2.htm CONSENT OF PRICEWATERHOUSECOOPERS LLP

 

SUMMIT THERAPEUTICS INC. FORM S-3

 

EX-23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Summit Therapeutics Inc. of our report dated March 31, 2021 relating to the financial statements, which appears in Summit Therapeutics Inc.'s Form 10-K/A for the year ended December 31, 2021. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

 

/s/PricewaterhouseCoopers LLP

Reading, United Kingdom
December 21, 2022

 

 

1